Objectives: The aim of this study was to compare the efficacy and safety of drug-eluting stent (DES) and bare-metal stent (BMS) use in chronic total occlusion (CTO) recanalization.
Background: The long-term effectiveness and safety of DES use in CTO recanalization are unclear, and performance of randomized clinical trials in the field is complex.
Methods: Major electronic information sources were explored for articles comparing outcomes with DES and BMS use among patients with CTO.